Symbiosis Pharmaceutical Services Ltd, a sterile biopharmaceutical Contract Manufacturing Organization (CMO), has purchased new premises in Stirling, Scotland, UK, which will significantly increase manufacturing capacity, strengthen the current Symbiosis commercial manufacturing service offering, and expedite the fast delivery of clients’ sterile injectable drug products to clinical trials and commercial markets.   Close to its existing manufacturing cleanrooms, testing laboratories, and GMP w...